The influence of ifosfamide scheduling on acute nephrotoxicity in children (Q36431761)

14 August 2017

The influence of ifosfamide scheduling on acute nephrotoxicity in children (English)

1 reference

14 August 2017

1 reference

English MW

1

1 reference

14 August 2017

Skinner R

2

1 reference

14 August 2017

Pearson AD

3

1 reference

14 August 2017

Price L

4

1 reference

14 August 2017

Wyllie R

5

1 reference

14 August 2017

Craft AW

6

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

75

1 reference

14 August 2017

1356-1359

1 reference

14 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1997.229

14 August 2017

0 references

cites work

Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Ifosfamide, mesna, and nephrotoxicity in children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Nephrotoxicity after ifosfamide

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Assessment of chemotherapy-associated nephrotoxicity in children with cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Ifosfamide-induced Fanconi's syndrome with growth failure in a 2-year-old child

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Progressive renal toxicity due to ifosfamide

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Ifosfamide, Fanconi's syndrome, and rickets

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

The influence of age on nephrotoxicity following chemotherapy in children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Renal function abnormalities after ifosfamide treatment in children

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228242

Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics

21 September 2018

1 reference

12 December 2020

The assessment of subclinical ifosfamide-induced renal tubular toxicity using urinary excretion of retinol-binding protein

1 reference

12 December 2020

Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children

1 reference

12 December 2020

Comparison of continuous infusion and bolus administration of ifosfamide in children

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.229

1 reference

14 August 2017

1 reference

14 August 2017

1 reference